Europe
The England and Wales High Court’s ruling in Accord v Novartis may not rewrite the law on plausibility, but it does signal a pragmatic approach that could provide greater certainty for life sciences innovators
Two recent decisions demonstrate the courts’ creativity in cutting-edge IP disputes that tested their jurisdictional powers
As UPC activity continues to drive strategic hiring and expansion, recent rulings have delivered a notable win for Samsung, and further uncertainty in the long-running GSK-Pfizer vaccine battle
Patrade has turned to experienced IP practitioner and business development leader Anders Isaksson to strengthen its commercial strategy and expand its reach to clients across Scandinavia
Sponsored
Sponsored
-
Sponsored by MaiwaldChristian Meyer of Maiwald discusses a case concerning the domain muenchen.de, in which a reference to a USB stick was found to be admissible in an application for an injunction -
Sponsored by Gün + PartnersSelin Sinem Erciyas and Zeynep Çağla Üstün of Gün and Partners consider how far patent protection remains an obstacle to accessing COVID-19 vaccines
-
Sponsored by InspicosJakob Pade Frederiksen of Inspicos P/S explains the EBA’s G 1/21 decision
-
Sponsored by Gorodissky & PartnersVladimir Biriulin of Gorodissky & Partners considers a trademark dispute ruling by the Chamber of Patent Disputes, concerning alcoholic beverages in Class 33
-
Sponsored by Gün + PartnersZeynep Seda Alhas and Dilan Sıla Kayalıca of Gün and Partners consider the Turkish IP court’s ruling on an infringement case by Red Bull
-
Sponsored by Bird & BirdWilliam Warne of Bird & Bird describes why some recent judgments have the potential to significantly alter the dynamic in UK FRAND cases
European Jurisdictions